Most Medicare plans cover Eliquis (apixaban), which doctors may use to treat atrial fibrillation (AFib) and to help treat and prevent some types of blood clots. The Medicare Part D drug plan you ...
Results highlighted in two oral presentations at the American Society of Hematology Annual Meeting In a second oral presentation, results from a sub-group analysis of the primary study were ...
ELIQUIS demonstrated superior efficacy versus enoxaparin 40 mg once daily without increased bleeding ELIQUIS is the only oral anticoagulant with a 12- to 24-hour post surgery initiation window First ...
The European Committee for Medicinal Products for Human Use (CHMP) has recommended approval for apixaban (Eliquis, Pfizer and BristolMyers Squibb) for atrial fibrillation (AF). The drug is already ...
Forbes contributors publish independent expert analyses and insights. I'm a medical journalist covering cardiology news. The Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation ...
Blood thinner Eliquis has been a major growth driver for Bristol-Myers Squibb and partner Pfizer, as well as the overall biopharma sector. Now, though, the blockbuster earner might face some cheaper ...
FDA Accepts ELIQUIS® (apixaban) New Drug Application for Review for the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation PRINCETON, N.J. & NEW YORK--(BUSINESS ...
Bristol Myers Squibb and Pfizer have launched an online programme to sell their blockbuster anticoagulant Eliquis directly to patients, following in the footsteps of Eli Lilly and Novo Nordisk in a ...
Princeton, NJ and New York, NY - The US FDA has requested more information from Bristol-Myers Squibb and Pfizer for the new anticoagulant apixaban (Eliquis) for the indication of prevention of stroke ...
For eight years, Beth Joyner Waldron has counted on Eliquis to treat clots in her lungs and legs. In November 2021, she received a letter from CVS Caremark telling her the pharmacy benefit manager is ...
Eliquis 360 Support Program Now Offers Eliquis to Cash-Paying Patients at More than 40% Discount to Current List Price PRINCETON, N.J.--(BUSINESS WIRE)-- The Bristol Myers Squibb-Pfizer (BMS NYSE: BMY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results